Adverse events following immunization with oral poliovirus in Kinshasa, Democratic Republic of Congo: Preliminary results

Pathogens and Global Health

Volumn 107, Issue 7, 2013, Pages 381-384

  Nzolo, Didier ^a   Aloni, Michel Ntetani ^a   Ngamasata, Thérèse Mpiempie ^a   Luemba, Bibiche Mvete ^a   Marfeza, Sandrine Bazundama ^a   Ekila, Mathilde Bothale ^a   Nsibu, Célestin Ndosimao ^a   Tona, Narcisse Lutete ^a  

^a UNIVERSITY OF KINSHASA   (Congo)

Author keywords

Adverse events following immunization; Democratic Republic of Congo; Kinshasa; Oral poliovirus; Students

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; ASTHMA; BACKACHE; CHILD; CONJUNCTIVITIS; COUGHING; CROSS-SECTIONAL STUDY; DEMOCRATIC REPUBLIC CONGO; DIARRHEA; DIZZINESS; DRUG RECHALLENGE; DYSPNEA; FEMALE; FEVER; HEADACHE; HUMAN; IMMUNIZATION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALAISE; MALE; MUSCLE WEAKNESS; MUSCULOSKELETAL PAIN; NAUSEA AND VOMITING; PARALYSIS; PHARYNGITIS; POLIOMYELITIS VIRUS; PRURITUS; QUESTIONNAIRE; RASH; RHINITIS; RISK; URTICARIA;

ADVERSE EVENTS FOLLOWING IMMUNIZATION,; DEMOCRATIC REPUBLIC OF CONGO; KINSHASA,; ORAL POLIOVIRUS,; STUDENTS,;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; POPULATION SURVEILLANCE; QUESTIONNAIRES;

EID: 84892759970     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773213Y.0000000113     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses-worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep. 2012;61:741-6.
2. Centers for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses-worldwide, July 2009-March 2011. MMWR Morb Mortal Wkly Rep. 2011;60(25):846-50.
3. Schumacher Z, Bourquin C, Heininger U. Surveillance for adverse events following immunization (AEFI) in Switzerland-1991-2001. Vaccine. 2010;28:4059-64.
4. Ouandaogo CR, Yaméogo TM, Diomandé FV, Sawadogo C, Ouédraogo B, Ouédraogo-Traoré R, et al. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine. 2012;30:B46-51.
5. Lund N, Andersen A, Monteiro I, Aaby P, Benn CS. No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experiment. Vaccine. 2012;30:6694-9.
6. Le Menach A, Llosa AE, Mouniaman-Nara I, Kouassi F, Ngala J, Boxall N, et al. Poliomyelitis outbreak, Pointe-Noire, Republic of the Congo, September 2010-February 2011. Emerg Infect Dis. 2011;17:1506-9.
7. Waldman EA, Luhm KR, Monteiro SA, de Freitas FR. Surveillance of adverse effects following vaccination and safety of immunization programs. Rev Saude Publica. 2011;45:173-84.
8. Ankrah DN, Mantel-Teeuwisse AK, De Bruin ML, Amoo PK, Ofei-Palm CN, Agyepong I, et al. Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective study. Drug Saf. 2013;36:259-66.
9. Ouandaogo CR, Yaméogo TM, Diomandé FV, Sawadogo C, Ouédraogo B, Ouédraogo-Traoré R, et al. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine. 2012;30:B46-51.
10. Mahajan D, Roomiani I, Gold MS, Lawrence GL, McIntyre PB, Menzies RI. Annual report: surveillance of adverse events following immunization in Australia, 2009. Commun Dis Intell Q Rep. 2010;34:259-76.
11. World Health Organization, Department of Vaccines and Biological. Supplementary information on vaccine safety; Part 2: Background rates of adverse events following immunization [document on the Internet]. WHO/V&B/00.36. Geneva: ISO; December 2000 [cited 2013 Jun 24]. Available from: http:// whqlibdoc.who.int/hq/2000/WHO_V&B_00.36.pdf